Xiangbo An

973 total citations
28 papers, 740 citations indexed

About

Xiangbo An is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Xiangbo An has authored 28 papers receiving a total of 740 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Xiangbo An's work include Cardiac Fibrosis and Remodeling (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Cardiovascular Effects of Exercise (3 papers). Xiangbo An is often cited by papers focused on Cardiac Fibrosis and Remodeling (4 papers), Cardiovascular Function and Risk Factors (3 papers) and Cardiovascular Effects of Exercise (3 papers). Xiangbo An collaborates with scholars based in China, Romania and United States. Xiangbo An's co-authors include Youyi Zhang, Yao Song, Yunpeng Xie, Xiao Yang, Feng Wang, Zhenhua Li, Lantao Liu, Nian Liu, Guan Yang and Song Zuo and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and Hypertension.

In The Last Decade

Xiangbo An

28 papers receiving 734 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangbo An China 17 390 238 236 91 72 28 740
Cui Liang China 15 382 1.0× 209 0.9× 180 0.8× 61 0.7× 86 1.2× 27 604
Zeqi Zheng China 17 381 1.0× 158 0.7× 191 0.8× 77 0.8× 89 1.2× 48 786
Nicoleta Alexandru Romania 17 389 1.0× 199 0.8× 200 0.8× 101 1.1× 73 1.0× 32 714
Zulong Xie China 12 336 0.9× 137 0.6× 141 0.6× 120 1.3× 80 1.1× 31 608
Changlin Zhai China 15 392 1.0× 276 1.2× 131 0.6× 64 0.7× 56 0.8× 38 741
Yachen Zhang China 14 389 1.0× 255 1.1× 165 0.7× 73 0.8× 61 0.8× 22 658
Meiling Yan China 16 466 1.2× 151 0.6× 160 0.7× 101 1.1× 90 1.3× 42 808
Yunfei Bian China 15 258 0.7× 121 0.5× 198 0.8× 86 0.9× 121 1.7× 38 644
Jianbin Gong China 17 312 0.8× 104 0.4× 176 0.7× 132 1.5× 127 1.8× 49 760
Dulguun Amgalan United States 7 549 1.4× 175 0.7× 182 0.8× 70 0.8× 129 1.8× 9 858

Countries citing papers authored by Xiangbo An

Since Specialization
Citations

This map shows the geographic impact of Xiangbo An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangbo An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangbo An more than expected).

Fields of papers citing papers by Xiangbo An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangbo An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangbo An. The network helps show where Xiangbo An may publish in the future.

Co-authorship network of co-authors of Xiangbo An

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangbo An. A scholar is included among the top collaborators of Xiangbo An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangbo An. Xiangbo An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yitong, Xiangbo An, Feng Wang, & Yinong Jiang. (2024). Ginsenoside RH4 inhibits Ang II-induced myocardial remodeling by interfering with NFIL3. Biomedicine & Pharmacotherapy. 172. 116253–116253. 6 indexed citations
2.
Wang, Yao, Jinjin Zhang, Yunsong Wang, et al.. (2024). Ubiquitin-like modifier-activating enzyme 1 as a potential therapeutic target for aortic dissection. International Immunopharmacology. 145. 113742–113742. 2 indexed citations
3.
Wang, Jie, et al.. (2023). Ginaton reduces M1-polarized macrophages in hypertensive cardiac remodeling via NF-κB signaling. Frontiers in Pharmacology. 14. 1104871–1104871. 3 indexed citations
4.
Wang, Yao, Jinjin Zhang, Xiangbo An, et al.. (2023). Hyperhomocysteinaemia Promotes Doxorubicin-Induced Cardiotoxicity in Mice. Pharmaceuticals. 16(9). 1212–1212. 6 indexed citations
5.
Wang, Xuwen, et al.. (2023). The relationship between geometry and hemodynamics of the stenotic carotid artery based on computational fluid dynamics. Clinical Neurology and Neurosurgery. 231. 107860–107860. 6 indexed citations
6.
An, Xiangbo, Yao Wang, Jinjin Zhang, et al.. (2023). Severe hypertriglyceridemia caused by Gpihbp1 deficiency facilitates vascular remodeling through increasing endothelial activation and oxidative stress. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(7). 159330–159330. 2 indexed citations
7.
Deng, Yawen, Xiangbo An, Yao Wang, et al.. (2022). Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension. Oxidative Medicine and Cellular Longevity. 2022(1). 1486157–1486157. 17 indexed citations
8.
Liao, Jiawei, Jie Bai, Xiangbo An, et al.. (2021). Lipoprotein Glomerulopathy-Like Lesions in Atherosclerotic Mice Defected With HDL Receptor SR-B1. Frontiers in Cardiovascular Medicine. 8. 734824–734824. 2 indexed citations
9.
10.
Liu, Yang, Haichen Lv, Xiangbo An, et al.. (2020). Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts. Hypertension. 76(6). 1856–1867. 36 indexed citations
11.
Wang, Liang, et al.. (2020). Quercetin Dihydrate inhibition of cardiac fibrosis induced by angiotensin II in vivo and in vitro. Biomedicine & Pharmacotherapy. 127. 110205–110205. 44 indexed citations
12.
Liu, Lantao, Yao Song, Linling Li, et al.. (2018). GW29-e1174 The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Journal of the American College of Cardiology. 72(16). C36–C36. 1 indexed citations
13.
Zhang, Ying, et al.. (2018). Splenectomy had no significant impact on lipid metabolism and atherogenesis in Apoe deficient mice fed on a severe atherogenic diet. Cardiovascular Pathology. 36. 35–41. 10 indexed citations
14.
Guo, Xin, Mingming Gao, Yunan Wang, et al.. (2017). LDL Receptor Gene-ablated Hamsters: A Rodent Model of Familial Hypercholesterolemia With Dominant Inheritance and Diet-induced Coronary Atherosclerosis. EBioMedicine. 27. 214–224. 54 indexed citations
15.
Li, Zhenhua, Lantao Liu, Ning Hou, et al.. (2016). miR-199-sponge transgenic mice develop physiological cardiac hypertrophy. Cardiovascular Research. 110(2). 258–267. 44 indexed citations
16.
Liu, Lantao, Xiangbo An, Zhenhua Li, et al.. (2016). The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovascular Research. 111(1). 56–65. 190 indexed citations
17.
Wang, Jingjing, Yao Song, Hao Li, et al.. (2016). Exacerbated cardiac fibrosis induced by β‐adrenergic activation in old mice due to decreased AMPK activity. Clinical and Experimental Pharmacology and Physiology. 43(11). 1029–1037. 19 indexed citations
18.
Chen, Xiaohong, Xiangbo An, Dongrui Chen, et al.. (2016). Chronic Exercise Training Improved Aortic Endothelial and Mitochondrial Function via an AMPKα2-Dependent Manner. Frontiers in Physiology. 7. 631–631. 21 indexed citations
19.
Ma, Xiaowei, Yongnan Fu, Han Xiao, et al.. (2015). Cardiac Fibrosis Alleviated by Exercise Training Is AMPK-Dependent. PLoS ONE. 10(6). e0129971–e0129971. 63 indexed citations
20.
Sun, Lulu, Yanli Li, Qiuping Deng, et al.. (2014). Grb2-associated binder 1 is essential for cardioprotection against ischemia/reperfusion injury. Basic Research in Cardiology. 109(4). 420–420. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cui Liang Breakdown of academic impact, for papers by Zeqi Zheng Breakdown of academic impact, for papers by Nicoleta Alexandru Breakdown of academic impact, for papers by Zulong Xie Breakdown of academic impact, for papers by Changlin Zhai Breakdown of academic impact, for papers by Yachen Zhang Breakdown of academic impact, for papers by Meiling Yan Breakdown of academic impact, for papers by Yunfei Bian Breakdown of academic impact, for papers by Jianbin Gong Breakdown of academic impact, for papers by Dulguun Amgalan
Rankless by CCL
2026